Effect of Maternal Obesity on the Risk of Fetal Loss After Amniocentesis and Chorionic Villus Sampling

OBJECTIVE: To estimate the risk of fetal loss in obese women undergoing amniocentesis and chorionic villus sampling (CVS). METHODS: This was a retrospective cohort study of all women undergoing amniocentesis or CVS. The primary outcome was any fetal loss before 24 weeks of gestation. A secondary analysis was performed examining pregnancy loss within 14 days of the procedure, excluding termination of pregnancy. Obese (body mass index [BMI] 30.0 or higher) and nonobese (BMI lower than 30.0) patients were compared, and the postprocedure loss rate was also estimated by BMI strata. Obese and nonobese patients were compared with univariable and bivariate statistics; multivariable logistic regression models were developed to estimate the effect of maternal obesity. RESULTS: Between obese (n=2,742) and nonobese (n=8,037) women undergoing amniocentesis, no difference existed in the risk of fetal loss before 24 weeks of gestation (4.7% [combined background and procedure loss] compared with 4.2%, adjusted odds ratio [OR] 1.1, 95% confidence interval [CI] 0.8–1.5). For women undergoing CVS, no difference in the risk of pregnancy loss was seen between obese (n=855) and nonobese (n=4,125) women (6.4% compared with 6.3%, adjusted OR 1.0, 95% CI 0.7–1.3). Compared with women not undergoing a procedure, the attributable risk for obese women was 0.3% (95% CI −0.2 to 0.9) amniocentesis and 0.1% (95% CI −0.1 to 0.2) CVS. The difference in fetal loss between the BMI 40.0 or higher and BMI lower than 25.0 groups after amniocentesis was significant after adjusting for maternal age (adjusted OR 2.2, 95% CI 1.2–3.9). This study had greater than 90% power to detect a 50% increase in the risk of pregnancy loss after amniocentesis and CVS (with an &agr; error of 0.05). CONCLUSION: A BMI of 30.0–40.0 does not increase the risk for fetal loss after invasive prenatal diagnostic procedures. A higher loss rates with class III obesity (BMI 40.0 or higher) was observed for amniocentesis procedures. LEVEL OF EVIDENCE: II

[1]  J. Ickovics,et al.  Gestational weight gain and subsequent postpartum weight loss among young, low-income, ethnic minority women. , 2011, American journal of obstetrics and gynecology.

[2]  E. Pressman,et al.  Ultrasound screening for fetal aneuploidy using soft markers in the overweight and obese gravida , 2010, Prenatal diagnosis.

[3]  J. Ramsay,et al.  Impact of maternal obesity on procedure of mid-trimester anomaly scan , 2010, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[4]  James Troendle,et al.  Maternal obesity and congenital heart defects: a population-based study. , 2010, The American journal of clinical nutrition.

[5]  F. Malone,et al.  Influence of maternal BMI on genetic sonography in the FaSTER trial , 2010, Prenatal diagnosis.

[6]  B. Källén,et al.  Maternal obesity and morbid obesity: the risk for birth defects in the offspring. , 2009, Birth defects research. Part A, Clinical and molecular teratology.

[7]  Diane M Twickler,et al.  Effect of Maternal Obesity on the Ultrasound Detection of Anomalous Fetuses , 2009, Obstetrics and gynecology.

[8]  J. Rankin,et al.  Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. , 2009, JAMA.

[9]  S. Yagel,et al.  Evaluating the rate and risk factors for fetal loss after chorionic villus sampling. , 2009, Obstetrics and gynecology.

[10]  G. Macones,et al.  Revisiting the Fetal Loss Rate After Second-Trimester Genetic Amniocentesis: A Single Center’s 16-Year Experience , 2008, Obstetrics and gynecology.

[11]  Katherine M Flegal,et al.  Obesity among adults in the United States--no statistically significant change since 2003-2004. , 2007, NCHS data brief.

[12]  S. Lederman,et al.  Maternal Reporting of Prepregnancy Weight and Birth Outcome: Consistency and Completeness Compared with the Clinical Record , 1998, Maternal and Child Health Journal.